Literature DB >> 9046062

Characterisation of thyroid medullary carcinoma TT cell line.

M Zabel1, J Grzeszkowiak.   

Abstract

TT cell line is the best known stabilized cell line derived from the human medullary thyroid carcinoma. The ultrastructural characteristics of these cells include well developed rough endoplasmic reticulum, a prominent Golgi apparatus and a considerable number of secretory granules. Numerous hormones were immunocytochemically demonstrated in TT cells of which calcitonin and calcitonin gene-related peptide (CGRP) are the products of the same gene but an alternative RNA processing. TT cells were found to produce some other hormones as well, namely ACTH, neurotensin, enkephalin, PTHrP, gastrin-releasing peptide (GRP), serotonin but also functional proteins of the chromogranin group, synaptophysin, NSE, calbindin and tyrosine hydroxylase. Some marker proteins have been detected in the cytosol (CEA) and in the cytoskeleton (alpha-tubulin, cytokeratin). The influence of numerous factors on the secretory activity of these cells has been demonstrated so far, including effects of 1,25-dihydroxycholecalciferol, glucocorticoids, sex steroids, cAMP, gastrin-releasing peptide, sodium butyrate, phorbol esters, ionomycin and forskolin. The investigators performed on the TT cell line demonstrate that this is the most reliable model system for the human parafollicular cells developed so far, in comparison to other cell lines derived from the medullary carcinoma of the thyroid.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9046062

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  5 in total

1.  MEN2 Syndrome-Related Medullary Thyroid Carcinoma with Focal Tyrosine Hydroxylase Expression: Does It Represent a Hybrid Cellular Phenotype or Functional State of Tumor Cells?

Authors:  Ozgur Mete; Ahmed Essa; Anil Bramdev; Navendren Govender; Runjan Chetty
Journal:  Endocr Pathol       Date:  2017-12       Impact factor: 3.943

Review 2.  Metachronous appearance of second malignancies in medullary thyroid carcinoma (MTC) patients: a diagnostic challenge and brief review of the literature.

Authors:  Maria Alevizaki; Elena Kyratzoglou; Aristoteles Bamias; Marinella Tzanela; Meletios A Dimopoulos; Katerina Saltiki
Journal:  Endocrine       Date:  2013-04-23       Impact factor: 3.633

3.  Type 2 iodothyronine deiodinase is highly expressed in medullary thyroid carcinoma.

Authors:  Erika L Souza Meyer; Iuri M Goemann; José Miguel Dora; Marcia S Wagner; Ana Luiza Maia
Journal:  Mol Cell Endocrinol       Date:  2008-04-22       Impact factor: 4.102

4.  Upregulated miR-9-3p Promotes Cell Growth and Inhibits Apoptosis in Medullary Thyroid Carcinoma by Targeting BLCAP.

Authors:  Yangjing Chen; Shaoqiang Zhang; Ruimin Zhao; Qian Zhao; Ting Zhang
Journal:  Oncol Res       Date:  2016-11-17       Impact factor: 5.574

5.  Transcriptional targeting of oncogene addiction in medullary thyroid cancer.

Authors:  Anisley Valenciaga; Motoyasu Saji; Lianbo Yu; Xiaoli Zhang; Ceimoani Bumrah; Ayse S Yilmaz; Christina M Knippler; Wayne Miles; Thomas J Giordano; Gilbert J Cote; Matthew D Ringel
Journal:  JCI Insight       Date:  2018-08-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.